Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broad Spectrum Antibiotics for Early Stage CLL
NCT01279252Phase 2Completed
- Sponsor
- King's College Hospital
- Start
- Jul 2011
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metronidazole, clarithromycin, ciprofloxacin, lansoprazole in chronic lymphocytic leukemia (CLL), sponsored by King's College Hospital. Started Jul 2011; status: completed.
02
Drugs
metronidazoleclarithromycinciprofloxacinlansoprazole
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01279252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01279252.